TranS1, Inc.

Robbins Umeda LLP Announces the Filing of a Class Action Suit Against TranS1, Inc.

Robbins Umeda LLP announces the filing of a federal securities class action by an investor in the U.S. District Court for the Eastern District of North Carolina on behalf of purchasers of TranS1, Inc. (NASDAQ: TSON) shares between February, 21 2008 and October 17, 2011 (the “Class Period”).  Concerned shareholders who would like more information about their rights and potential remedies can complete the form below and we will contact you directly.  You can also contact attorney Gregory E. Del Gaizo at (800) 350-6003.

Robbins Umeda LLP announces the filing of a federal securities class action by an investor in the U.S. District Court for the Eastern District of North Carolina on behalf of purchasers of TranS1, Inc. (NASDAQ: TSON) shares between February, 21 2008 and October 17, 2011 (the “Class Period”).   Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Gregory E. Del Gaizo at (800) 350-6003, info@robbinsarroyo.com, or via the shareholder information form on the firm’s website.

The complaint alleges that beginning on February 21, 2008, certain officers and directors at TranS1 issued a series of positive statements to investors about the business condition, future prospects, and true performance of the company that were materially false and misleading.  In particular, the complaint alleges that officials at TranS1 withheld material adverse facts from investors that: (1) the company was not in compliance with federal healthcare fraud and false claim statutes; (2) TranS1 engaged in improper reimbursement practices; (3) the company lacked adequate internal and financial controls; and that (4) as a result of the foregoing, the company’s statements were materially false and misleading at all relevant times.

On October 17, 2011, TranS1 filed a Form 8-k with the U.S. Securities and Exchange Commission first disclosing that the company received a subpoena from the Department of Health and Human Services, under the authority of the federal healthcare fraud and false claims statutes.  On this news, TranS1 shares declined more than 40% to close at just $1.85 per share on October 18, 2011.   

Robbins Umeda LLP is a nationally recognized leader in securities litigation and shareholder rights law.  The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested.

 

Shareholder Information

Items marked with an asterisk (*) are required information.

First Name * Last Name *
Address City State/Province *
ZIP/Postal Code Country/Region Phone *
E-mail * Confirm: E-mail *

Shares Purchased:
Number of Shares: Buy Date : Price Per Share:
example: 125 example: MM/DD/YYYY example: 30.00
transaction:
transaction:
transaction:
transaction:
transaction:
If you have additional transactions or comments, please input the information below:

Shares Sold:
Number of Shares: Buy Date : Price Per Share:
example: 125 example: MM/DD/YYYY example: 30.00
transaction:
transaction:
transaction:
transaction:
transaction:
If you have additional transactions or comments, please input the information below:

Please Note: Neither the submission to nor the receipt of information by Robbins Umeda LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

* I have read the disclaimer information

    Send This Post

    Tags: